Abiopharma

Ares Raises $12.7 Billion to Invest in Asset-Based Finance Through the Pathfinder Closed-End Strategy

J.Jill, Inc. Announces First Quarter 2026 Results

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

MoneyHero Group to Announce First Quarter 2026 Results

Trane Technologies Names Donny Simmons as Chief Operating Officer

Immunic to Participate in Investor, Industry and Scientific Conferences in June

Director Dunde Yu 🟡 adjusted position in 0 shares (2 derivative) of Tuniu Corp (TOUR) at $3.00 ($5.4M) Transaction Date: Jun 08, 2026 | Filing ID: 072058

Akamai Earns the Solutions Partner with Certified Software Designation for Security

Carter’s Partners with Bubba Wallace and Boys & Girls Clubs of America to Strengthen Support for Today’s Parents

Tilray Medical Germany Launches ARX™, a New Premium Medical Cannabis Brand Cultivated in Germany

Accendra Health Announces Early Results of Offers and Consent Solicitations

TE Connectivity declares quarterly dividend

Immunic to Participate in Investor, Industry and Scientific Conferences in June

Parsons’ CUAS Solutions Strengthen National Security and Protect Critical Infrastructure

Amaze Showcases the Future of Creator-Led Businesses at VidCon 2026